At first glance, CRISPR gene editing looks like the solution to all the world's ills: it could treat or even cure diseases, improve birth rates and otherwise fix genetic conditions that previously seemed permanent. You might want to keep your expectations low, though. Scientists have published preliminary findings indicating that two variants of CRISPR Cas9 (the most common gene editing technique) might not work for most humans. In a study, between 65 percent and 79 percent of subjects had antibodies that would fight Cas9 proteins.
The potential reaction isn't shocking. Both Cas9 variants are based on common bacteria, S. aureus and S. pyrogenes, that tend to infect humans. However, that could also produce reactions that would be... unpleasant. At the least, they could "hinder the safe and effective use" of CRISPR to treat disease. And in the worst cases, they could result in "significant toxicity" for patients.
It's important to stress that the research hasn't been peer-reviewed yet. Geneticists might not need to go back to the drawing board just yet.
Source: https://www.engadget.com/2018/01/07/crispr-gene-editing-methods-might-not-work-for-most-humans/
(Score: 3, Interesting) by mobydisk on Tuesday January 09 2018, @11:20PM
Is CRISPR intended to be used on an adult human being, or on a child or embryo who has a known defect. The latter doesn't have a fully developed immune system yet.